Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,142 | 111 | 75.2% |
| Travel and Lodging | $852.40 | 4 | 20.4% |
| Education | $184.90 | 2 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus Corporation of the Americas | $1,017 | 7 | $0 (2018) |
| ABBVIE INC. | $782.70 | 26 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $501.37 | 4 | $0 (2020) |
| Janssen Biotech, Inc. | $477.04 | 14 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $219.95 | 14 | $0 (2021) |
| Olympus America Inc. | $128.40 | 1 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $127.98 | 7 | $0 (2018) |
| UCB, Inc. | $124.74 | 1 | $0 (2018) |
| Braintree Laboratories, Inc. | $118.18 | 8 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $109.67 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $62.29 | 2 | ABBVIE INC. ($48.85) |
| 2021 | $242.54 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($55.29) |
| 2020 | $331.79 | 10 | AbbVie Inc. ($177.11) |
| 2019 | $684.39 | 19 | AbbVie, Inc. ($154.10) |
| 2018 | $2,045 | 57 | Olympus Corporation of the Americas ($650.69) |
| 2017 | $813.33 | 20 | Olympus Corporation of the Americas ($366.12) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $48.85 | General |
| Category: IMMUNOLOGY | ||||||
| 01/07/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: Neuroscience | ||||||
| 12/02/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $55.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/25/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Immunology | ||||||
| 07/28/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $51.24 | General |
| Category: Neuroscience | ||||||
| 07/27/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| Category: Neuroscience | ||||||
| 07/21/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Gastroenterology | ||||||
| 03/24/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Immunology | ||||||
| 01/15/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GI COLON PREP | ||||||
| 12/03/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2020 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 10/21/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/04/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $99.54 | General |
| 02/20/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/12/2020 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $113.52 | General |
| Category: Immunology | ||||||
| 11/21/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $100.02 | General |
| Category: Virology | ||||||
| 11/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Lower GI | ||||||
| 11/07/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Viberzi, AHP/GIV | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Gastroenterology | ||||||
| 09/10/2019 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 512 | 566 | $272,645 | $52,524 |
| 2022 | 9 | 233 | 456 | $81,448 | $18,329 |
| 2021 | 12 | 430 | 935 | $124,951 | $35,509 |
| 2020 | 13 | 279 | 432 | $65,724 | $19,809 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 98 | 99 | $38,412 | $12,802 | 33.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 129 | $17,802 | $7,547 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $18,038 | $5,871 | 32.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 84 | 86 | $65,188 | $5,051 | 7.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 19 | 19 | $22,351 | $4,174 | 18.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $36,435 | $3,472 | 9.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 38 | $7,676 | $3,375 | 44.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 33 | $6,567 | $2,991 | 45.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $6,312 | $2,144 | 34.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $11,310 | $2,053 | 18.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 16 | 17 | $32,759 | $1,768 | 5.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $9,795 | $1,275 | 13.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 17 | 17 | $18,609 | $4,746 | 25.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 19 | 19 | $15,935 | $3,161 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 36 | $7,981 | $2,800 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,824 | $2,663 | 34.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 13 | 13 | $12,932 | $2,250 | 17.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $11,810 | $1,018 | 8.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 29 | 29 | $4,147 | $1,013 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,824 | $620.01 | 34.0% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2022 | 36 | 95 | $190.00 | $42.75 | 22.5% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2022 | 36 | 196 | $196.00 | $16.47 | 8.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 26 | 26 | $32,083 | $9,244 | 28.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 27 | 27 | $29,980 | $6,287 | 21.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 52 | $11,328 | $4,491 | 39.6% |
About Dr. Robert Bischoff, DO
Dr. Robert Bischoff, DO is a Gastroenterology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2014. The National Provider Identifier (NPI) number assigned to this provider is 1891106001.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Bischoff, DO has received a total of $4,180 in payments from pharmaceutical and medical device companies, with $62.29 received in 2022. These payments were reported across 117 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,142).
As a Medicare-enrolled provider, Bischoff has provided services to 1,454 Medicare beneficiaries, totaling 2,389 services with total Medicare billing of $126,172. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine
- Location Grand Rapids, MI
- Active Since 05/12/2014
- Last Updated 12/10/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1891106001
Products in Payments
- Endocuff Devices (Device) $1,017
- STELARA (Biological) $793.51
- Mavyret (Drug) $224.36
- REMICADE (Biological) $184.90
- Olympus Biliary Devices (Device) $128.40
- Trulance (Drug) $127.98
- Cimzia (Drug) $124.74
- RELISTOR (Drug) $119.03
- RENFLEXIS (Biological) $109.67
- ZEPOSIA (Drug) $92.41
- Creon (Drug) $91.69
- HUMIRA (Biological) $90.48
- Humira (Biological) $87.73
- XIFAXAN (Drug) $85.46
- SUPREP (Drug) $60.72
- MOVIPREP (Drug) $55.67
- MOTEGRITY (Drug) $55.29
- OCALIVA (Drug) $53.91
- NASCOBAL (Drug) $51.75
- SKYRIZI (Biological) $48.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Grand Rapids
John Papp, Md, MD
Gastroenterology — Payments: $10,115
Dr. Asif Azeem, M.d, M.D
Gastroenterology — Payments: $8,129
Randall Meisner, Md, MD
Gastroenterology — Payments: $7,979
Ryan Wong, Md, MD
Gastroenterology — Payments: $7,574
Lia Kaufman, Md, MD
Gastroenterology — Payments: $3,564
Dr. Mark Cooper, M.d, M.D
Gastroenterology — Payments: $3,211